Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Bioorg Med Chem Lett ; 23(4): 1036-40, 2013 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-23312471

RESUMO

From a series of N-acyl 4-(3-pyridonyl)phenylalanine derivatives of 4, the trifluoromethyl derivative 28 was identified as a potent, dual acting alpha4 integrin antagonist with activity in primate models of allergic asthma. Investigation of a series of prodrug esters led to the discovery of the morpholinopropyl derivative 48 that demonstrated good intestinal fluid stability, solubility and permeability. Compound 48 gave high blood levels of 28 when dosed orally in cynomolgus monkeys. Surprisingly, hydrolysis of 48 was rapid in liver microsomes from the pharmacological species, mouse, rat and monkey, but slow in dog and human; in vivo studies also indicated there was prolonged exposure to unchanged prodrug in dogs.


Assuntos
Integrina alfa4beta1/antagonistas & inibidores , Integrinas/antagonistas & inibidores , Fenilalanina/análogos & derivados , Animais , Cães , Ésteres/sangue , Ésteres/farmacologia , Humanos , Camundongos , Fenilalanina/farmacologia , Pró-Fármacos/química , Pró-Fármacos/farmacologia , Ratos
2.
Bioorg Med Chem Lett ; 23(4): 1026-31, 2013 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-23312474

RESUMO

N-Acyl 4-(5-pyrimidine-2,4-dionyl)phenylalanine derivatives of type 4 were designed to replace the 2,6-dichlorobenzoylamine portion of compound 1 in order to identify novel compounds with improved potency against α4-integrins. Several derivatives were identified as very potent dual-acting α4-integrin, α4ß1 and α4ß7 antagonists. Investigation of a limited number of prodrug esters led to the discovery of the ethyl ester prodrug 42, which demonstrated good intestinal fluid stability and good permeability. Despite low solubility, 42 gave acceptable blood levels of 30 when dosed orally in non-human primates. Additionally, 42 had an overall excellent profile and was selected for clinical trials. Investigation of N-acyl 4-(5-pyrimidine-2,4-dionyl)phenylalanine derivatives led to the discovery of several very potent dual-acting α4-integrin antagonists. Ethyl ester prodrug 42 advanced to human clinical trials based on the excellent intestinal fluid stability, good permeability and superior efficacy in non-human primates.


Assuntos
Integrina alfa4beta1/antagonistas & inibidores , Integrinas/antagonistas & inibidores , Fenilalanina/análogos & derivados , Pirimidinas/farmacologia , Animais , Cães , Ésteres/química , Ésteres/farmacocinética , Ésteres/farmacologia , Humanos , Macaca fascicularis , Camundongos , Fenilalanina/farmacocinética , Fenilalanina/farmacologia , Pró-Fármacos/química , Pró-Fármacos/farmacocinética , Pró-Fármacos/farmacologia , Pirimidinas/química , Pirimidinas/farmacocinética , Ratos , Relação Estrutura-Atividade
4.
Bioorg Med Chem ; 13(16): 4835-41, 2005 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-15953730
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...